Medicine
Glucotrol XL 5 mg extended-release tablet
Glucotrol XL 5 mg extended-release tablet is a prescription medicine containing Glipizide for oral use, marketed by Roerig, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 68–77°F (20–25°C), excursions permitted between 59°F and 86°F (15°C…
Key facts
- Active ingredient (INN)
- Glipizide
- Brand
- Glucotrol XL
- Strength
- 5 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets
- Marketing authorisation holder
- Roerig
- Manufacturer
- Roerig
- Origin register
- US FDA, United States
- Storage
- Store at 68–77°F (20–25°C), excursions permitted between 59°F and 86°F (15°C and 30°C). The tablets should be protected from moisture and humidity.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BB07 Glipizide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 May 2013
- Identifiers
- RxCUI 310489, 314006, 315107 +3DailyMed set ID eed99b60-d043-4249-9b2a-f05e46fb588dNDC 0049-0174Application NDA020329
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 8 May 1984 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Glipizide 5 mg extended-release tablet.
Other strengths and forms of Glipizide
Clinical summary
Glipizide is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets and extended-release tablets for oral use. MedsAcross supplies Glipizide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GlipizideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Glucotrol XL prescribing information (Roerig) · U.S. National Library of Medicine, DailyMed
Need Glucotrol XL 5 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.